Basınçlı İntraperitoneal Aerosol Kemoterapi (PIPAC) Prosedürü, Semptomları ve Hemşirelik Bakımı

Yıl 2025, Cilt: 5 Sayı: 1, 96 - 106, 30.04.2025

Emre Kuğu , Tuluha Ayoğlu

https://doi.org/10.56061/fbujohs.1456034

Öz

Basınçlı İntraperitoneal Aerosol Kemoterapi (PIPAC), minimal invaziv cerrahi şeklinde uygulanan bir kanser tedavi prosedürüdür. Karın boşluğuna trokarlar yardımı ile uygulanan aerosolize edilmiş kemoterapi ilaçlarının kanser hücrelerine direkt etki etmesinin hedeflendiği bir tedavi yöntemidir. Bu yöntem, kanser hücrelerine maksimum etki sağlamayı ve sistemik toksisiteyi azaltmayı amaçlar. PIPAC tedavisinin avantajları ve dezavantajları bulunmaktadır. Bu nedenle ameliyathane hemşiresinin birçok görevi vardır. PIPAC işlemi çeşitli semptomlara neden olabilir. Cerrahi prosedüre bağlı en sık görülen semptomlar karın ağrısı, kanama, derin ven trombozu, bağırsak tıkanıklığı ve asittir. Kemoterapi ilaçlarının mide ve bağırsaklara etkisi nedeniyle alerji, tat kaybı, bulantı ve kusma meydana gelebilirken, bağırsaklarda tahriş de ishale yol açabilmektedir. Semptomların etkisi hastanın yaşam kalitesini ve tedaviye olan uyumunu etkileyebilir. Bu nedenle, PIPAC işlemi öncesi ve sonrasında hastaya uygun önlemler alınmalıdır. Hemşireler, semptomları izlemeli ve hastaları gerektiğinde cerrahları ile iletişime geçmeleri konusunda yönlendirmelidir. Hasta bilgilendirilmeli, semptomlar ile karşılaşırsa ne yapması gerektiği hakkında bilgi sahibi olmalı ve gerekirse hemşireler tarafından ilaçlar uygulanmalıdır. Hastalara psikososyal destek sağlamak önemlidir. Sonuç olarak, PIPAC işlemi uygulanan hastalarda prosedüre bağlı semptomlar etkili bir şekilde yönetilmelidir ve bu konuda ameliyathane hemşireleri önemli bir rol oynamaktadır.

Anahtar Kelimeler

Hemşirelik bakımı , PIPAC , İntraperitoneal kemoterapi

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Procedure, Complications and Nursing Care

Öz

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) is a minimally invasive surgical cancer treatment procedure. It is a treatment method in which aerosolized chemotherapy drugs administered into the abdominal cavity with the help of trocars are aimed at acting directly on cancer cells. This method aims to maximize the effect on cancer cells and reduce systemic toxicity. The PIPAC treatment has advantages and disadvantages. Therefore, the operating room nurse has many tasks. The PIPAC procedure can cause various symptoms. The most common symptoms related to the surgical procedure are abdominal pain, bleeding, deep vein thrombosis, intestinal obstruction, and ascites. Allergies, loss of taste, nausea, and vomiting can occur due to the effect of chemotherapy drugs on the stomach and intestines, while irritation of the intestines can lead to diarrhea. The impact of symptoms can affect the patient's quality of life and compliance with treatment. Therefore, appropriate precautions should be taken before and after the PIPAC procedure. Nurses should monitor symptoms and guide patients to contact their surgeon if necessary. The patient should be informed about what to do if they experience symptoms, and medications should be administered by nurses if necessary. It is important to provide psychosocial support to patients. In conclusion, procedure-related symptoms should be managed effectively in patients undergoing PIPAC procedures, and operating room nurses play an important role in this regard.

Anahtar Kelimeler

Intraperitoneal Chemotherapy , Nursing Care , PIPAC

Kaynakça

• Alyami, M., Bonnot, P. E., Mercier, F., Laplace, N., Villeneuve, L., Passot, G., Bakrin, N., Kepenekian, V., & Glehen, O. (2021). Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer. European Journal of Surgical Oncology, 47(1), 123–127. https://doi.org/10.1016/j.ejso.2020.05.021
• Alyami, M., Hübner, M., Grass, F., Bakrin, N., Villeneuve, L., Laplace, N., Passot, G., Glehen, O., & Kepenekian, V. (2019). Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications. The Lancet Oncology, 20(7), 368-677. https://doi.org/10.1016/S1470-2045(19)30318-3
• Bakkers, C., Rovers, K. P., Rijken, A., Simkens, G. A. A. M., Bonhof, C. S., Nienhuijs, S. W., Burger, J. W. A., Creemers, G. J. M., Brandt-Kerkhof, A. R. M., Tuynman, J. B., Aalbers, A. G. J., Wiezer, M. J., de Reuver, P. R., van Grevenstein, W. M. U., Hemmer, P. H. J., Punt, C. J. A., Tanis, P. J., Mols, F., de Hingh, I. H. J. T., … Koopman, M. (2023). Perioperative systemic therapy versus cytoreductive surgery and HIPEC alone for resectable colorectal peritoneal metastases: Patient-reported outcomes of a randomized phase II trial. Annals of Surgical Oncology, 30(5), 2678–2688. https://doi.org/10.1245/s10434-023-13116-z
• Balmer, A., Clerc, D., Toussaint, L., Sgarbura, O., Taïbi, A., Hübner, M., & Farinha, H. T. (2022). Selection criteria for pressurized intraperitoneal aerosol chemotherapy (PIPAC) treatment in patients with peritoneal metastases. Cancers 14(10), 2557. https://doi.org/10.3390/cancers14102557
• Ben Aziz, M., & Di Napoli, R. (2023). Hyperthermic intraperitoneal chemotherapy. In StatPearls. StatPearls Publishing.
• Bhatt, A., Mittal, S., & Gopinath, K. S. (2016). Safety considerations for health care workers involved in cytoreductive surgery and perioperative chemotherapy. Indian Journal of Surgical Oncology, 7(2), 249–257. https://doi.org/10.1007/s13193-016-0503-7
• Case, A., Prosser, S., Peters, C. J., Adams, R., Gwynne, S., & PIPAC UK Collaborative. (2022). Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) for gastric cancer with peritoneal metastases: A systematic review by the PIPAC UK collaborative. Critical Reviews in Oncology/Hematology, 180, 103846. https://doi.org/10.1016/j.critrevonc.2022.103846
• Chellam Singh, B., & Arulappan, J. (2023). Operating room nurses’ understanding of their roles and responsibilities for patient care and safety measures in intraoperative practice. SAGE Open Nursing, 9, 23779608231186247. https://doi.org/10.1177/23779608231186247
• Clerc, D., Hübner, M., Ashwin, K. R., Somashekhar, S. P., Rau, B., Ceelen, W., Willaert, W., Bakrin, N., Laplace, N., Al Hosni, M., Garcia Lozcano, E. L., Blaj, S., Piso, P., Di Giorgio, A., Vizzelli, G., Brigand, C., Delhorme, J. B., Klipfel, A., Archid, R., … Sgarbura, O. (2021). Current practice and perceptions of safety protocols for the use of intraperitoneal chemotherapy in the operating room: Results of the IP-OR international survey. Pleura and Peritoneum, 6(1), 39–45. https://doi.org/10.1515/pp-2020-0148
• Deng, H., Li, B., & Qin, X. (2022). The short- and long-term survival of hyperthermic intraperitoneal chemotherapy (HIPEC) in the advanced gastric cancer with/without peritoneal carcinomatosis: a systematic review and meta-analysis of randomized controlled trials. Updates in Surgery, 74(6), 1805–1816. https://doi.org/10.1007/s13304-022-01376-5
• Di Giorgio, A., Macrì, A., Ferracci, F., Robella, M., Visaloco, M., De Manzoni, G., Sammartino, P., Sommariva, A., Biacchi, D., Roviello, F., Pastorino, R., Pires Marafon, D., Rotolo, S., Casella, F., & Vaira, M. (2023). 10 Years of pressurized intraperitoneal aerosol chemotherapy (PIPAC): A Systematic review and meta-analysis. Cancers, 15(4), 1125. https://doi.org/10.3390/cancers15041125
• Dunn, D., Ciccarelli, E., & Moltzen, N. (2019). Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy, Part II: Implementation. AORN Journal, 110(6), 606–625. https://doi.org/10.1002/aorn.12865
• Ellebæk, S. B., Graversen, M., Detlefsen, S., Lundell, L., Fristrup, C. W., Pfeiffer, P., & Mortensen, M. B. (2020). Pressurized intraperitoneal aerosol chemotherapy (PIPAC)-directed treatment of peritoneal metastasis in end-stage colo-rectal cancer patients. Pleura and Peritoneum, 5(2), 20200109. https://doi.org/10.1515/pp-2020-0109
• Girardot-Miglierina, A., Clerc, D., Alyami, M., Villeneuve, L., Sgarbura, O., Reymond, M. A., & Hübner, M. (2021). Consensus statement on safety measures for pressurized intraperitoneal aerosol chemotherapy. Pleura and Peritoneum, 6(4), 139–149. https://doi.org/10.1515/pp-2021-0125
• Graversen, M., Detlefsen, S., Bjerregaard, J. K., Fristrup, C. W., Pfeiffer, P., & Mortensen, M. B. (2018). Prospective, single-center implementation and response evaluation of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis. Therapeutic Advances in Medical Oncology, 10. https://doi.org/10.1177/1758835918777036
• Hu, J., Wang, Z., Wang, X., & Xie, S. (2023). Side-effects of hyperthermic intraperitoneal chemotherapy in patients with gastrointestinal cancers. PeerJ, 11, Article e15277. https://doi.org/10.7717/peerj.15277
• Hübner, M., Kusamura, S., Villeneuve, L., Al-Niaimi, A., Alyami, M., Balonov, K., Bell, J., Bristow, R., Guiral, D. C., Fagotti, A., Falcão, L. F. R., Glehen, O., Lambert, L., Mack, L., Muenster, T., Piso, P., Pocard, M., Rau, B., Sgarbura, O., … Nelson, G. (2020). Guidelines for perioperative care in cytoreductive surgery (CRS) with or without hyperthermic intraperitoneal chemotherapy (HIPEC): Enhanced recovery after surgery (ERAS®) Society Recommendations — Part I: Preoperative and intraoperative management. European Journal of Surgical Oncology 46(12), 2292–2310. https://doi.org/10.1016/j.ejso.2020.07.041
• Jansen-Winkeln, B., Eberth, J., Moulla, Y., Mehdorn, M., Niebisch, S., Schierle, K., Bläker, H., Lordick, F., Gockel, I., & Thieme, R. (2023). Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal surface malignancies (PSM): a prospective single-center registry study. Journal of Cancer Research and Clinical Oncology 149(3), 1331–1341. https://doi.org/10.1007/s00432-022-04517-w
• Khosrawipour, V., Khosrawipour, T., Diaz-Carballo, D., Förster, E., Zieren, J., & Giger-Pabst, U. (2016). Exploring the spatial drug distribution pattern of pressurized intraperitoneal aerosol chemotherapy (PIPAC). Annals of Surgical Oncology, 23(4), 1220–1224. https://doi.org/10.1245/s10434-015-4954-9
• Li, X. B., Peng, K. W., Ji, Z. H., Yu, Y., Liu, G., & Li, Y. (2019). Prevention of venous thromboembolism after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Development of a physiotherapy program. Clinical and Applied Thrombosis/Hemostasis, 25, 1076029619890415. https://doi.org/10.1177/1076029619890415
• Lundbech, M., Krag, A. E., Iversen, L. H., & Hvas, A. M. (2022). Postoperative bleeding and venous thromboembolism in colorectal cancer patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis. International Journal of Colorectal Disease, 37(1), 17–33. https://doi.org/10.1007/s00384-021-04021-6
• Mimouni, M., Richard, C., Adenot, P., Letheule, M., Tarrade, A., Sandra, O., Dahirel, M., Lilin, T., Lecuelle, B., Gélin, V., Cohen, J., Fauconnier, A., Vialard, F., Huchon, C., & Chavatte-Palmer, P. (2021). Pressurized intra-peritoneal aerosol chemotherapy (PIPAC): increased intraperitoneal pressure does not affect distribution patterns but leads to deeper penetration depth of doxorubicin in a sheep model. BMC Cancer, 21(1), 461. https://doi.org/10.1186/s12885-021-07955-w
• Mohammad, A., Hor, M., Baradeiya, A. M., Qasim, H., & Nasr, M. (2022). Is Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) effective in ovarian cancer with peritoneal metastasis? Cureus, 14(8), Article e27837. https://doi.org/10.7759/cureus.27837
• Nadiradze, G., Horvath, P., Sautkin, Y., Archid, R., Weinreich, F. J., Königsrainer, A., & Reymond, M. A. (2020). Overcoming drug resistance by taking advantage of physical principles: Pressurized intraperitoneal aerosol chemotherapy (PIPAC). Cancers, 12(1), 34. https://doi.org/10.3390/cancers12010034
• Papadakis, M., Meiwandi, A., & Grzybowski, A. (2019). The WHO safer surgery checklist time out procedure revisited: Strategies to optimise compliance and safety. International Journal of Surgery, 69, 19–22. https://doi.org/10.1016/j.ijsu.2019.07.006
• Park, S. J., Lee, E. J., Seol, A., Park, S., Ham, J., Yim, G. W., Shim, S. H., Lim, W., Chang, S. J., Song, G., Park, J. W., & Kim, H. S. (2022). Rotational intraperitoneal pressurized aerosol chemotherapy with paclitaxel and cisplatin: pharmacokinetics, tissue concentrations, and toxicities in a pig model. Journal of Gynecologic Oncology, 33(5), Article e56. https://doi.org/10.3802/jgo.2022.33.e56
• Račkauskas, R., Baušys, A., Lukšta, M., Jurgaitis, J., Paškonis, M., & Strupas, K. (2021). Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal malignancy: initial experience of the first program in the Baltic countries. World Journal of Surgical Oncology, 19(1), 236. https://doi.org/10.1186/s12957-021-02357-5
• Robella, M., Hubner, M., Sgarbura, O., Reymond, M., Khomiakov, V., di Giorgio, A., Bhatt, A., Bakrin, N., Willaert, W., Alyami, M., Teixeira, H., Kaprin, A., Ferracci, F., De Meeus, G., Berchialla, P., Vaira, M., Villeneuve, L., Cortés-Guiral, D., Nowacki, M., … Vizzielli, G. (2022). Feasibility and safety of PIPAC combined with additional surgical procedures: PLUS study. European Journal of Surgical Oncology, 48(10), 2212–2217. https://doi.org/10.1016/j.ejso.2022.05.001
• Rouche, A., Hübner, M., Grass, F., Pache, B., Demartines, N., & Blanc, C. (2020). Anaesthesia in a toxic environment: Pressurised intraperitoneal aerosol chemotherapy: A retrospective analysis. Turkish Journal of Anaesthesiology and Reanimation, 48(4), 273–279. https://doi.org/10.5152/TJAR.2019.15493
• Ryu, J. H., & Koo, C. H. (2021). Anesthetic concerns during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Korean Journal of Anesthesiology, 74(2), 89–90. https://doi.org/10.4097/kja.21099
• Sgarbura, O., Eveno, C., Alyami, M., Bakrin, N., Guiral, D. C., Ceelen, W., Delgadillo, X., Dellinger, T., Di Giorgio, A., Kefleyesus, A., Khomiakov, V., Mortensen, M. B., Murphy, J., Pocard, M., Reymond, M., Robella, M., Rovers, K. P., So, J., Somashekhar, S. P., … Hübner, M. (2022). Consensus statement for treatment protocols in pressurized intraperitoneal aerosol chemotherapy (PIPAC). Pleura and Peritoneum, 7(1), 1–7. https://doi.org/10.1515/pp-2022-0102
• Shree, V., Lim, T. J., Lean, L. L., So, B. Y. J., & Kim, G. (2020). Anaesthesia considerations and techniques for Pressurised IntraPeritoneal Aerosol Chemotherapy (PIPAC). Pleura and Peritoneum, 5(4). https://doi.org/10.1515/pp-2019-0013
• Siebert, M., Alyami, M., Mercier, F., Gallice, C., Villeneuve, L., Bérard, F., Glehen, O., Bakrin, N., & Kepenekian, V. (2019). Severe hypersensitivity reactions to platinum compounds post-pressurized intraperitoneal aerosol chemotherapy (PIPAC): first literature report. Cancer Chemotherapy and Pharmacology, 83(3), 425–430. https://doi.org/10.1007/s00280-018-3740-3
• Solanki, S., Mukherjee, S., Agarwal, V., Thota, R., Balakrishnan, K., Shah, S., Desai, N., Garg, R., Ambulkar, R., Bhorkar, N., Patro, V., Sinukumar, S., Venketeswaran, M., Joshi, M., Chikkalingegowda,
• R., Gottumukkala, V., Owusu-Agyemang, P., Saklani, A., Mehta, S., … Divatia, J. (2019). Society of Onco-Anaesthesia and perioperative care consensus guidelines for perioperative management of patients for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC). Indian Journal of Anaesthesia, 63(12), 972–987. https://doi.org/10.4103/ija.IJA_765_19
• Teixeira Farinha, H., Grass, F., Kefleyesus, A., Achtari, C., Romain, B., Montemurro, M., Demartines, N., & Hübner, M. (2017). Impact of pressurized intraperitoneal aerosol chemotherapy on quality of life and symptoms in patients with peritoneal carcinomatosis: A Retrospective cohort study. Gastroenterology Research and Practice, 2017. https://doi.org/10.1155/2017/4596176
• Tidadini, F., Abba, J., Quesada, J. L., Villeneuve, L., Foote, A., Baudrant, M., Bonne, A., Glehen, O., Trilling, B., Faucheron, J. L., & Arvieux, C. (2022). Assessment of postoperative pain after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the treatment of peritoneal metastasis. International Journal of Colorectal Disease, 37(7), 1709–1717. https://doi.org/10.1007/s00384-022-04182-y
• Tidadini, F., Trilling, B., Quesada, J. L., Abba, J., Foote, A., Faucheron, J. L., & Arvieux, C. (2024). Impact of body mass index on postoperative pain and opioid administration after pressurized intraperitoneal aerosol chemotherapy (PIPAC). Journal of Gastrointestinal Cancer, 55(1), 297–306. https://doi.org/10.1007/s12029-023-00957-w
• Valle, S. J., Alzahrani, N. A., Alzahrani, S. E., Liauw, W., & Morris, D. L. (2015). Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for refractory malignant ascites in patients unsuitable for cytoreductive surgery. International Journal of Surgery, 23(Pt A), 176–180. https://doi.org/10.1016/j.ijsu.2015.09.074
• Vallicelli, C., Coccolini, F., Sartelli, M., Ansaloni, L., Bui, S., & Catena, F. (2022). Antibiotic prophylaxis for surgical site infection in general surgery: Oncological treatments and HIPEC. Antibiotics, 11(1), 43. https://doi.org/10.3390/antibiotics11010043
• van Stein, R. M., Lok, C. A. R., Aalbers, A. G. J., H.J.T. de Hingh, I., Houwink, A. P. I., Stoevelaar, H. J., Sonke, G. S., & van Driel, W. J. (2022). Standardizing HIPEC and perioperative care for patients with ovarian cancer in the Netherlands using a Delphi-based consensus. Gynecologic Oncology Reports, 39. https://doi.org/10.1016/j.gore.2022.100945
• Wahidi, K. R., & Milanti, A. (2022). Oncology nurses’ role in the enhanced recovery after surgery programme. Asia-Pacific Journal of Oncology Nursing, 9(7), 100033. https://doi.org/10.1016/j.apjon.2022.01.008
• Wajekar, A. S., Solanki, S. L., & Patil, V. P. (2022). Postoperative complications and critical care management after cytoreduction surgery and hyperthermic intraperitoneal chemotherapy: A systematic review of the literature. World Journal of Critical Care Medicine, 11(6), 375–386. https://doi.org/10.5492/wjccm.v11.i6.375
• Wang, X., & Li, T. (2020). Postoperative pain pathophysiology and treatment strategies after CRS + HIPEC for peritoneal cancer. World Journal of Surgical Oncology, 18(1), 62. https://doi.org/10.1186/s12957-020-01842-7
• Weibel, S., Rücker, G., Eberhart, L. H. J., Pace, N. L., Hartl, H. M., Jordan, O. L., Mayer, D., Riemer, M., Schaefer, M. S., Raj, D., Backhaus, I., Helf, A., Schlesinger, T., Kienbaum, P., & Kranke, P. (2020). Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis. Cochrane Database of Systematic Reviews, 10(10). https://doi.org/10.1002/14651858.CD012859.pub2
• Yurttas, C., Hoffmann, G., Tolios, A., Haen, S. P., Schwab, M., Königsrainer, I., Königsrainer, A., Beckert, S., & Löffler, M. W. (2018). Systematic review of variations in hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastasis from colorectal cancer. Journal of Clinical Medicine, 7(12), 567. https://doi.org/10.3390/jcm7120567